QT
FLXN

Quantamental Technologies’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Quantamental Technologies’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,449
Closed -$42K – 1934
2019
Q2 		$42K Buy
3,449
+2,608
+310% +$30.1K 0.02% 952
2019
Q1 		$10K Sell
841
-754
-47% -$10.1K ﹤0.01% 1232
2018
Q4 		$18K Buy
+1,595
New +$25K 0.01% 1042

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Quantamental Technologies's FLXN Position: Q3 2019 in Review

Quantamental Technologies sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2019, closing a stake of 3,449 shares — an estimated $42K sold.

Quantamental Technologies first reported a position in FLXN in Q4 2018 and held it in 3 quarters. The position peaked at $42K in Q2 2019. 126 funds tracked by Wall St. Rank hold FLXN as of Q3 2019.

  • Quantamental Technologies reported no remaining Flexion Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Quantamental Technologies sold 3,449 Flexion Therapeutics, Inc. shares in Q3 2019, an estimated $42K.
  • Quantamental Technologies first reported a position in Flexion Therapeutics, Inc. in Q4 2018 and held it in 3 quarters.
  • Quantamental Technologies's Flexion Therapeutics, Inc. position peaked at $42K in Q2 2019.
  • 126 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2019.

Based on Quantamental Technologies's 13F filing for Q3 2019, filed 8 Nov 2019.